Printer Friendly

Articles from M2 Pharma (March 23, 2016)

1-19 out of 19 article(s)
Title Author Type Words
Acutus Medical Raises USD 75m from New, Existing Investors. 286
Aratana Therapeutics files second US FDA approval for first-in-class ghrelin agonist ENTYCE for dogs. 155
Blood Cell Storage to introduce SAFE Sens TrakStation / TrakPod continuous pH monitoring systems in Spain via Concile Diagnostics SL. 227
Diversigen signs strategic partnership with BioCore in Korea for microbiome/metagenomic genetic services. 136
Eiger BioPharmaceuticals concludes merger agreement with Celladon. 154
Eli Lilly and Company passes the US FDA's approval for Taltz (ixekizumab) injection 80 mg/ml for treating severe plaque psoriasis in adult patients. 272
Elusys Therapeutics receives US FDA approval for ANTHIM. 206
Evotec announces spin off of new Topas Therapeutics GmbH. 270
Genisphere signs PDT collaborative research agreement with the University of Pennsylvania. 217
Halt Medical Hires Bridges as President, CEO. 254
Harvard University signs exclusive license and research collaboration agreement with Merck. 239
Iridex Issued US Patent Approvals Covering TxCell-Guided MicroPulse Laser Therapy. 257
LEO Pharma receives EU scientific approval for psoriasis drug Enstilar. 226
Moberg Pharma signs development and licensing agreement with Cadila Pharmaceuticals for BUPI. 224
OncBioMune Pharmaceuticals names new member to Scientific Advisory Board. 170
OncoQuest partners with Shenzhen Hepalink Pharmaceutical Co to fund the research and development of cancer immunotherapies in China via OncoVent Co. 247
Profounda unveils US FDA approved Impavido (miltefosine) for visceral, mucosal and cutaneous leishmaniasis in the US. 279
Sosei names new representative executive officer and chief operating officer. 216
US Digital X-ray System Market to Reach USD 2.48bn by 2019, Technavio Predicts. 475

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters